UNITED STATES OF AMERICA et al v. CVS HEALTH CORPORATION et al

  1. June 06, 2019

    The $69 Billion Questions From The CVS-Aetna Judge

    Across two days and six witnesses, the combative D.C. federal judge reviewing the U.S. Department of Justice deal clearing the CVS-Aetna merger asked many questions — some mundane, some probing — that shed light on what factors he'll consider before ruling on the $69 billion tie-up. Here are some of the highlights.

  2. June 05, 2019

    CVS Gets Aetna's 'Huge Collection Of Customers,' Judge Says

    The D.C. federal judge reviewing the U.S. Department of Justice deal clearing the CVS-Aetna merger on Wednesday expressed doubt about the companies' claim that the tie-up won't give them leverage over rival pharmacy benefit managers.

  3. June 04, 2019

    'Should I Limit Myself?' CVS-Aetna Merger Judge Asks

    The D.C. federal judge reviewing the U.S. Department of Justice deal clearing the CVS-Aetna merger on Tuesday still appeared to be grappling with how broad the scope of his first-of-its-kind evidentiary proceeding should be.

  4. May 31, 2019

    In CVS-Aetna, A Novel Review For A Major Industry Shakeup

    When CVS and Aetna go to court Tuesday to defend their $69 billion tie-up, they’ll face a confrontational judge presiding over an unprecedented trial-like review of the merger settlement the companies brokered with the U.S. Department of Justice. Here, Law360 looks at how the judge is breaking the mold for merger reviews and what the outcome could mean.

  5. May 29, 2019

    AMA Says Hearing Slated For CVS-Aetna Deal Good As Is

    The American Medical Association pushed back Wednesday against a bid by the U.S. Department of Justice to reshape a hearing scheduled next week over the agency's deal that cleared CVS' purchase of Aetna by urging a D.C. federal judge to keep the hearing's planned format.

  6. May 28, 2019

    DOJ Says It's Being Left Out Of Upcoming CVS-Aetna Hearing

    The U.S. Department of Justice told the judge overseeing the court review of its deal clearing CVS' purchase of Aetna that the hearing scheduled for next month risks leaving the government out of the process.

  7. May 17, 2019

    No Delay For CVS-Aetna Deal Review

    The U.S. Department of Justice deal clearing the CVS-Aetna merger remains bound for review with live witness testimony in early June after a D.C. federal judge rejected CVS Health Corp.'s bid to delay the first-of-its-kind review by more than a month.

  8. May 16, 2019

    State AGs Want In On CVS-Aetna Deal Review

    Attorneys general from California, Florida and three other states that helped the U.S. Department of Justice craft a deal clearing the CVS and Aetna merger want time to defend the agreement amid the deal's unusual review process playing out in D.C. federal court.

  9. May 13, 2019

    DOJ's CVS-Aetna Deal Set For Review, But Don't Call It A Trial

    The U.S. Department of Justice deal clearing CVS' $69 billion purchase of Aetna will be subjected to three days of live witness testimony next month in a scaled-down version of what a D.C. federal judge had indicated could be in store in the first-of-its-kind evidentiary proceeding.

  10. May 06, 2019

    CVS-Aetna Settlement Testimony To Last More Than 19 Hours

    Witness testimony is expected to last well over 19 hours in the unprecedented mini-trial over the settlement terms the Department of Justice imposed when it cleared CVS' $69 billion acquisition of Aetna, according to witness lists submitted by the parties Friday.